Bossi P - Search Results

1

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab.

Bossi P, Bergamini C, Siano M, Cossu Rocca M, Sponghini AP, Favales F, Giannoccaro M, Marchesi E, Cortelazzi B, Perrone F, Pilotti S, Locati LD, Licitra L, Canevari S, De Cecco L. Bossi P, et al. Clin Cancer Res. 2016 Aug 1;22(15):3961-70. doi: 10.1158/1078-0432.CCR-15-2547. Epub 2016 Feb 26. Clin Cancer Res. 2016. PMID: 26920888

2

Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma.

Sanguineti G, Bossi P, Pou A, Licitra L. Sanguineti G, et al. Among authors: bossi p. Clin Oncol (R Coll Radiol). 2003 Dec;15(8):451-60. doi: 10.1016/s0936-6555(03)00201-2. Clin Oncol (R Coll Radiol). 2003. PMID: 14690000 Review.

3

Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?

Licitra L, Bossi P, Locati L, Zunino F. Licitra L, et al. Among authors: bossi p. J Clin Oncol. 2004 Jan 15;22(2):377; author reply 377-8. doi: 10.1200/JCO.2004.99.219. J Clin Oncol. 2004. PMID: 14722048 No abstract available.

4

Head and neck tumors other than squamous cell carcinoma.

Licitra L, Locati LD, Bossi P, Cantù G. Licitra L, et al. Among authors: bossi p. Curr Opin Oncol. 2004 May;16(3):236-41. doi: 10.1097/00001622-200405000-00008. Curr Opin Oncol. 2004. PMID: 15069319 Review.

5

Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy.

Palazzi M, Guzzo M, Bossi P, Tomatis S, Cerrotta A, Cantú G, Locati LD, Licitra L. Palazzi M, et al. Among authors: bossi p. Tumori. 2004 Jan-Feb;90(1):60-5. doi: 10.1177/030089160409000114. Tumori. 2004. PMID: 15143974 Clinical Trial.

6

Head and neck cancer.

Licitra L, Locati LD, Bossi P. Licitra L, et al. Among authors: bossi p. Ann Oncol. 2004;15 Suppl 4:iv267-73. doi: 10.1093/annonc/mdh937. Ann Oncol. 2004. PMID: 15477319 Free article. Review. No abstract available.

7

Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.

Locati LD, Rinaldi G, Bossi P, Dagrada GP, Quattrone P, Cantú G, Licitra L. Locati LD, et al. Among authors: bossi p. Oral Oncol. 2005 Jan;41(1):97-8. doi: 10.1016/j.oraloncology.2004.03.002. Oral Oncol. 2005. PMID: 15598592 No abstract available.

8

Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.

Licitra L, Suardi S, Bossi P, Locati LD, Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantù G, Pierotti MA, Pilotti S. Licitra L, et al. Among authors: bossi p. J Clin Oncol. 2004 Dec 15;22(24):4901-6. doi: 10.1200/JCO.2004.05.071. J Clin Oncol. 2004. PMID: 15611505 Clinical Trial.

9

Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland.

Locati LD, Guzzo M, Bossi P, Massone PP, Conti B, Fumagalli E, Bareggi C, Cantù G, Licitra L. Locati LD, et al. Among authors: bossi p. Oral Oncol. 2005 Oct;41(9):890-4. doi: 10.1016/j.oraloncology.2005.04.014. Oral Oncol. 2005. PMID: 16043380

10

Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer?

Licitra L, Bossi P, Locati LD, Bergamini C. Licitra L, et al. Among authors: bossi p. J Clin Oncol. 2005 Oct 20;23(30):7757-8; author reply 7758-9. doi: 10.1200/JCO.2005.02.7854. J Clin Oncol. 2005. PMID: 16234549 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters